home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

HAART to Heart

  July, 2 2009 10:25
your information resource in human molecular genetics
'HIV-infected' patients with normal blood pressure, who are on certain anti-virus drugs, are more likely to have a high level of arterial stiffness that is similar to otherwise healthy patients with high blood pressure, reports a paper online in the American Journal of Hypertension. The effects may not be severe enough to halt therapy and the research does not establish a causative link.

Previous studies have shown that HIV patients treated with highly active retroviral therapy (HAART), which is commonly used to treat for HIV infection, had a greater degree of arterial stiffness than those HIV infected patients who were not treated with HAART. Arterial stiffness has been associated with increased risk of cardiovascular disease in patients with high blood pressure. The current study by Ignatios Ikonomidis and colleagues provides an important perspective for understanding the link between HIV infection, HAART use, and the premature development of cardiovascular disease that occurs in HIV-infected patients, even when their blood pressure is in the normal range.

HAART treatment is used in patients with more severe manifestations of HIV infection. Therefore, the authors cautioned that the design of their study does not permit them to conclude whether the higher level of arterial stiffness during HAART treatment was related to HAART use or to other effects that may be related to HIV disease severity or its duration.

Author contact:

Ignatios Ikonomidis (University of Athens, Greece)
E-mail: ignoik@otenet.gr

(C) American Journal of Hypertension press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.